cost control

Summary

Summary: The containment, regulation, or restraint of costs. Costs are said to be contained when the value of resources committed to an activity is not considered excessive. This determination is frequently subjective and dependent upon the specific geographic area of the activity being measured. (From Dictionary of Health Services Management, 2d ed)

Top Publications

  1. ncbi Cancer care, money, and the value of life: whose justice? Which rationality?
    Daniel P Sulmasy
    The John J Conley Department of Ethics, St Vincent s Hospital Manhattan and New York Medical College, New York, NY 10011, USA
    J Clin Oncol 25:217-22. 2007
  2. ncbi Contrary to cost-shift theory, lower Medicare hospital payment rates for inpatient care lead to lower private payment rates
    Chapin White
    Center for Studying Health System Change, Washington, DC, USA
    Health Aff (Millwood) 32:935-43. 2013
  3. pmc Medicaid cost control measures aimed at second-generation antipsychotics led to less use of all antipsychotics
    William B Vogt
    Terry College of Business, University of Georgia, Athens, GA, USA
    Health Aff (Millwood) 30:2346-54. 2011
  4. ncbi Pharmaceutical cost control in Canada: does it work?
    D Menon
    Institute of Health Economics, and University of Alberta, Edmonton
    Health Aff (Millwood) 20:92-103. 2001
  5. ncbi Whither seniors' pharmacare: lessons from (and for) Canada
    Steven G Morgan
    Centre for Health Services and Policy Research, University of British Columbia
    Health Aff (Millwood) 22:49-59. 2003
  6. pmc Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization
    Sebastian Schneeweiss
    Department of Epidemiology, Harvard School of Public Health, Boston, Mass, USA
    CMAJ 166:737-45. 2002
  7. ncbi [Assessment of the pharmaceutical expenditure in Hungary]
    András Inotai
    Semmelweis Egyetem, Egyetemi Gyógyszertár Gyógyszerügyi Szervezési Intézet, Budapest, Hogyes E u 9 1092
    Acta Pharm Hung 80:162-72. 2010
  8. ncbi Attitudes toward managed care and cost containment among primary care trainees at 3 training sites
    S A Skootsky
    Office of Education, Development and Research, School of Medicine, University of California, UCLA Medical Plaza, Los Angeles, CA 90095, USA
    Am J Manag Care 5:1397-404. 1999
  9. ncbi Group purchasing of pharmaceuticals and medical supplies by the Gulf Cooperation Council states
    T A M Khoja
    Executive Office of the GCC States for Health Ministers, Riyadh, Saudi Arabia
    East Mediterr Health J 11:217-25. 2005
  10. ncbi Does therapeutic reference pricing always result in cost-containment? The Hungarian evidence
    Zoltan Kalo
    Novartis Hungary Ltd, Budapest, Hungary
    Health Policy 80:402-12. 2007

Detail Information

Publications273 found, 100 shown here

  1. ncbi Cancer care, money, and the value of life: whose justice? Which rationality?
    Daniel P Sulmasy
    The John J Conley Department of Ethics, St Vincent s Hospital Manhattan and New York Medical College, New York, NY 10011, USA
    J Clin Oncol 25:217-22. 2007
    ..Oncologists would then be free to advocate for their patients within the constraints imposed by this public process...
  2. ncbi Contrary to cost-shift theory, lower Medicare hospital payment rates for inpatient care lead to lower private payment rates
    Chapin White
    Center for Studying Health System Change, Washington, DC, USA
    Health Aff (Millwood) 32:935-43. 2013
    ..My findings indicate that repealing cuts in Medicare payment rates would not slow the growth in spending on hospital care by private insurers and would in fact be likely to accelerate the growth in private insurers' costs and premiums...
  3. pmc Medicaid cost control measures aimed at second-generation antipsychotics led to less use of all antipsychotics
    William B Vogt
    Terry College of Business, University of Georgia, Athens, GA, USA
    Health Aff (Millwood) 30:2346-54. 2011
    ..Comparative effectiveness research should guide physicians and health plans on appropriate first treatments, while prior authorization policies should focus on moving patients to appropriate second-line therapies when necessary...
  4. ncbi Pharmaceutical cost control in Canada: does it work?
    D Menon
    Institute of Health Economics, and University of Alberta, Edmonton
    Health Aff (Millwood) 20:92-103. 2001
    ..Total drug spending in the country continues to rise, however; clearly, mechanisms other than price controls will need to be developed if drug spending is to be better managed...
  5. ncbi Whither seniors' pharmacare: lessons from (and for) Canada
    Steven G Morgan
    Centre for Health Services and Policy Research, University of British Columbia
    Health Aff (Millwood) 22:49-59. 2003
    ..Sustainable and equitable pharmacare programs require the political willingness to confront opposition to policies that will, if successful, contain program costs without obstructing access...
  6. pmc Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization
    Sebastian Schneeweiss
    Department of Epidemiology, Harvard School of Public Health, Boston, Mass, USA
    CMAJ 166:737-45. 2002
    ..The objective of this study was to analyze the effect of reference-based pricing of angiotensin-converting enzyme (ACE) inhibitors on drug utilization, cost savings and potential substitution with other medication classes...
  7. ncbi [Assessment of the pharmaceutical expenditure in Hungary]
    András Inotai
    Semmelweis Egyetem, Egyetemi Gyógyszertár Gyógyszerügyi Szervezési Intézet, Budapest, Hogyes E u 9 1092
    Acta Pharm Hung 80:162-72. 2010
    ..In order to improve the allocative efficiency of health care spending, available resources should be spent only on effective, cost-effective, economically affordable medicines...
  8. ncbi Attitudes toward managed care and cost containment among primary care trainees at 3 training sites
    S A Skootsky
    Office of Education, Development and Research, School of Medicine, University of California, UCLA Medical Plaza, Los Angeles, CA 90095, USA
    Am J Manag Care 5:1397-404. 1999
    ....
  9. ncbi Group purchasing of pharmaceuticals and medical supplies by the Gulf Cooperation Council states
    T A M Khoja
    Executive Office of the GCC States for Health Ministers, Riyadh, Saudi Arabia
    East Mediterr Health J 11:217-25. 2005
    ..It also discusses the future of the group purchasing programme in the light of globalization and how the international changes under the World Trade Organization agreements will affect the programme in future...
  10. ncbi Does therapeutic reference pricing always result in cost-containment? The Hungarian evidence
    Zoltan Kalo
    Novartis Hungary Ltd, Budapest, Hungary
    Health Policy 80:402-12. 2007
    ..Based upon the first experiences of the Hungarian implementation, the method described in this paper for the extension of generic reference pricing to therapeutic categories is not justifiable...
  11. ncbi [Pharmaceutical reference pricing in Germany: definition of therapeutic groups, price setting through regression procedure and effects]
    T Stargardt
    Technische Universitat Berlin, Fachgebiet Management im Gesundheitswesen
    Gesundheitswesen 67:468-77. 2005
    ..Nevertheless, compared to other instruments of price-regulation, reference pricing seems to be a good alternative to control pharmaceutical prices, since rationing is kept as little as possible...
  12. ncbi Current national initiatives about drug policies and cost control in Europe: the Italy example
    Francesca Rocchi
    Direzione Generale sui Farmaci e Dispositivi Medici Ministerio della Salute, Rome, Italy
    J Ambul Care Manage 27:127-31. 2004
    ..The set of interventions yielded a new national formulary that was able to have a significant influence on the trend of drug expenditure in Italy. This experience can be a useful reference for other European and non-European states...
  13. ncbi [Incentives in primary care from cost containment to public health]
    Juan Gervas
    Rev Esp Salud Publica 81:589-96. 2007
  14. ncbi A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing
    Helen Prosser
    Prescribing Research Group, Department of Pharmacology and Therapeutics, The Infirmary, 70 Pembroke Place, Liverpool L69 3GF, UK
    Soc Sci Med 60:1335-46. 2005
    ..GPs largely applied simple cost-minimization while cost-consideration was undermined by contextual factors. Implications for research and policy are discussed...
  15. ncbi European healthcare policies for controlling drug expenditure
    Silvia M Ess
    Hirslanden Research, Zurich, Switzerland
    Pharmacoeconomics 21:89-103. 2003
    ..Policies intended to affect physicians' prescribing behaviour include guidelines, information (about price and less expensive alternatives) and feedback, and the use of budgetary restrictions...
  16. pmc Physicians' views on resource availability and equity in four European health care systems
    Samia A Hurst
    Institute for Biomedical Ethics, Geneva University Medical School, Switzerland
    BMC Health Serv Res 7:137. 2007
    ..The perception of physicians, who witness the effects of these strategies, may provide useful insights regarding the impact of system-wide priority setting on access to care...
  17. ncbi Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia
    Steven G Morgan
    Centre for Health Services and Policy Research, University of British Columbia, 429 2194 Health Sciences Mall, Vancouver, BC, Canada V6T 1Z3
    Health Policy 68:299-307. 2004
    ..Changes in the mix of therapies and the type of product selected explained over half of the observed drug expenditure inflation. Increased generic substitution significantly reduced the price of products selected over the period...
  18. ncbi Managing oncology costs
    Claiborne E Reeder
    University of South Carolina College of Pharmacy, 715 Sumter Street, Coker Life Sciences Bldg, Room 109, Columbia, SC 29208, USA
    Am J Manag Care 12:S3-16; quiz S17-9. 2006
    This monograph will review the burden of illness in oncology, suggest a framework for evaluating oncology costs and consequences, identify economic modeling formats in cancer care, and explore methods of cost control for cancer care.
  19. ncbi Proposal of the Physicians' Working Group for Single-Payer National Health Insurance
    Steffie Woolhandler
    Department of Medicine, Cambridge Hospital Harvard Medical School, Cambridge, Mass 02139, USA
    JAMA 290:798-805. 2003
    ..An NHI program is the only affordable option for universal, comprehensive coverage...
  20. ncbi Perceptions of cost constraints, resource limitations, and rationing in United States intensive care units: results of a national survey
    Nicholas S Ward
    Division of Pulmonary Critical Care, Brown Medical School, Providence, RI, USA
    Crit Care Med 36:471-6. 2008
    ..To examine cost constraints, resource limitations, and rationing within U.S. intensive care units (ICUs) as perceived by ICU clinicians and the roles of ICU physician and nurse directors in resource allocation decisions...
  21. pmc Surgeon-led initiatives cut costs and enhance the quality of endoscopic and laparoscopic procedures
    Jeff W Allen
    Department of Surgery, University of Louisville School of Medicine, Center for Advanced Surgical Technologies of Norton Hospital, Louisville, Kentucky 40292, USA
    JSLS 7:243-7. 2003
    Public perception depicts surgical cost control and quality of care as polar opposites...
  22. ncbi Disease burden profiles: an emerging tool for managing managed care
    Yang Zhao
    DxCG, Inc, Boston, MA 02111, USA
    Health Care Manag Sci 5:211-9. 2002
    ..We also examine and compare the predictive power of claims-based models within a diabetic cohort...
  23. ncbi Absence of appropriate hospitalization cost control for patients with medical insurance: a comparative analysis study
    Xilong Pan
    Peking University Health Science Center, Health Policy and Management Department, School of Public Health, Beijing, People s Republic of China
    Health Econ 18:1146-62. 2009
    ..Expose the weak loops in the Chinese medical insurance coverage and uncover hospitals' role of over-pricing hospitalized insured patients compared with those non-insured...
  24. ncbi The importance of understanding the costs of critical care and mechanical ventilation
    Dale M Needham
    Crit Care Med 33:1434-5. 2005
  25. pmc Practicing surgeons lead in quality care, safety, and cost control
    Eugene H Shively
    Department of Surgery, University of Louisville School of Medicine and Quality Surgical Solutions, PLLC, Louisville, KY, USA
    Ann Surg 239:752-60; discussion 760-2. 2004
    ..To report the experiences of 66 surgical specialists from 15 different hospitals who performed 43 CPT-based procedures more than 16,000 times...
  26. pmc Issues in the acquisition, development, and use of technology in health care
    Raymond J Lanzafame
    Via Health, Rochester General Hospital, Rochester, New York, USA
    JSLS 10:401-8. 2006
  27. ncbi Decentralized responsibility for costs of outpatient prescription pharmaceuticals in Sweden. Assessment of models for decentralized financing of subsidies from a management perspective
    Gina Bergström
    Department of Social Medicine, Sahlgrenska Academy at Goteborg University, SE 405 30 Goteborg, Sweden
    Health Policy 81:358-67. 2007
    ..Experiences from other reforms in health care support this hypothesis. This means that there is a risk that cost containment jeopardises medical decisions on patient level...
  28. ncbi Reducing waste of intravenous solutions
    L D Diehl
    Tripler Army Medical Center, Honolulu, HI
    Am J Hosp Pharm 49:106-8. 1992
    ..By using several methods to reduce the waste of i.v. solutions, a pharmacy department has limited the rate of waste to only 3.27%...
  29. ncbi Physicians' ethical beliefs about cost-control arrangements
    D P Sulmasy
    The John J Conley Department of Ethics, St Vincents Hospital, New York, NY 10011, USA
    Arch Intern Med 160:649-57. 2000
    ..Although much has been written about the ethics of new methods of health care financing, little is known about the extent to which physicians experience these cost-control arrangements as ethical problems...
  30. ncbi The cost escalation of social health insurance plans in China: its implication for public policy
    X Liu
    Department of Social Medicine, Shandong Medical University, Jinan, People s Republic of China
    Soc Sci Med 41:1095-101. 1995
    ..4% between 1985-1989. Chinese experience also shows that demand strategy (co-payment by patients) had very little effect to contain cost escalation...
  31. ncbi Health care as a fixed-cost industry: implications for delivery
    Paul A Taheri
    Center for Health Care Economics, University of Michigan, Ann Arbor, MI 48109, USA
    Surg Innov 12:365-71. 2005
    ..Elements include flexing intensive care unit beds, improving operating room efficiencies, and rationalizing health care capacity...
  32. ncbi Patients' attitudes toward cost control bonuses for managed care physicians
    T H Gallagher
    Division of General Medical Sciences, Department of Medicine, Washington University School of Medicine, St. Louis, USA
    Health Aff (Millwood) 20:186-92. 2001
    ..To understand how patients view these incentives, we interviewed 1,050 patients regarding a 10 percent cost control bonus and a combined cost control/quality bonus...
  33. ncbi Moving beyond the drug budget silo mentality in Europe
    Michael Drummond
    Centre for Health Economics, University of York, York, UK
    Value Health 6:S74-7. 2003
  34. ncbi Encourage all to keep costs down. We must take steps to return control of healthcare dollars, decisions to individuals
    Ron Paul
    United States House of Representatives, USA
    Mod Healthc 37:22. 2007
  35. ncbi Controlling costs of critical care requires new focus
    Zvi Herschman
    Anesth Analg 97:607; author reply 607-8. 2003
  36. ncbi Why McCain has the best health-care plan
    Shawn Tully
    Fortune 157:143-4, 146. 2008
  37. ncbi Drug-altered states. As pharmaceutical spending continues to soar, state legislatures are taking bold steps to rein in their costs
    Jeff Tieman
    Mod Healthc 32:28-31. 2002
  38. ncbi Mergers and health care organizations
    Diana V Shaw
    Brigham and Women s OBGYN Department, Harvard Medical School, USA
    J Health Care Finance 29:28-37. 2003
    ..It reviews issues raised by mergers and examines a few case studies of merged health care organizations...
  39. ncbi Using disease management and market reforms to address the adverse economic effects of drug budgets and price and reimbursement regulations in Germany
    Tim Schwermann
    Center of Health Economics and Health System Research, University of Hannover, Hannover, Germany
    Value Health 6:S20-30. 2003
    ..Over the past decade, a number of specific budgeting initiatives were introduced to control drug spending-with some success, at least until the 11% increase in the first 6 months of 2001...
  40. ncbi Look beyond budgets to the broader benefits
    Robert Dugal
    Policy, Planning and Research, Rx and D, Ottawa
    Healthc Pap 3:77-82; discussion 87-94. 2002
    ..Patient health management is a strategy that deserves a closer look to achieve this goal...
  41. ncbi Pharmacy discount card programs: catching up with the health markets
    Drew Edwards
    Kenco Insurance Agency, Louisville, Kentucky, USA
    Empl Benefits J 27:42-3. 2002
    ..Pharmacy costs continue to rise, as does the number of senior citizens. One of the ways of containing costs may be the pharmacy discount drug card program, for both seniors and the general population...
  42. ncbi Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients
    Chien Wen Tseng
    Department of Family Practice and Community Health, University of Hawaii, and Pacific Health Research Institute, Honolulu, USA
    JAMA 290:222-7. 2003
    ..Annual dollar limits, or "caps," on drug benefits are common in Medicare managed care (Medicare + Choice) and have been part of several proposals for a national Medicare drug benefit...
  43. ncbi The drug budget silo mentality: the French case
    Claude Le Pen
    University of Paris Dauphine, Paris, France
    Value Health 6:S10-9. 2003
    ....
  44. ncbi Managing in the "new" era of managed care
    Michael Alper
    Meridian Healthcare Management, Woodland Hills, CA, USA
    Manag Care Q 10:24-9. 2002
    ....
  45. pmc Access to affordable medications: the Department of Veterans Affairs pharmacy plan as a national model
    Chester B Good
    Am J Public Health 97:2129-31. 2007
  46. ncbi The "R" word
    M Gregg Bloche
    Georgetown University Law Center, USA
    J Contemp Health Law Policy 18:633-9. 2002
  47. ncbi Components of spending for Medicaid Mental Health Services, 2001
    Tami L Mark
    Medstat, Washington, DC, USA
    Psychiatr Serv 56:648. 2005
  48. ncbi Managed competition using both market-driven and regulatory strategies
    Thomas P Weil
    Health and Hospital Service, Asheville, NC, USA
    Manag Care Q 10:32-40. 2002
    ....
  49. ncbi The impact of a national prescription drug formulary on prices, market share, and spending: lessons for Medicare?
    Haiden A Huskamp
    Department of Health Care Policy, Harvard Medical School, USA
    Health Aff (Millwood) 22:149-58. 2003
    ..We find that the VHA National Formulary was effective at shifting prescribing behavior toward the selected drugs, achieving sizable price reductions from manufacturers, and greatly decreasing drug spending...
  50. ncbi Getting the cat back in the bag: reforming the way provinces manage drug expenditures to make them manageable
    Adrian R Levy
    Centre for Health Evaluation and Outcome Sciences, St Paul s Hospital, Department of Health Care and Epidemiology, University of British Columbia, Vancouver
    Healthc Pap 3:32-7; discussion 87-94. 2002
    ..The question of how to implement the recommendations remains to be elucidated, as does an evaluation of the trade-offs between costs and benefits of obtaining better information on cost-effectiveness...
  51. ncbi More of the same is not enough
    Donald J Willison
    Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario
    Healthc Pap 3:47-55; discussion 87-94. 2002
    ..Better evidence and better dissemination are simply not enough...
  52. ncbi AOA Symposium. Gainsharing in orthopaedics: passing fancy or wave of the future?
    Douglas R Dirschl
    Department of Orthopaedics, University of North Carolina, Chapel Hill, NC 27599 7055, USA
    J Bone Joint Surg Am 89:2075-83. 2007
  53. ncbi Andrew Webber: a champion for value-driven health care
    Andrew Webber
    Healthc Financ Manage 61:30-2, 34. 2007
  54. ncbi Rx for Medicaid: with Medicaid costs rising and revenues declining, states are looking at what to do
    Laura Tobler
    State Legis 29:16-20. 2003
  55. ncbi The consumer-driven approach: can it pick up where managed care left off?
    Steve Halterman
    Benefits Q 19:13-26. 2003
    ..This article discusses the failure of managed care and ways that employers can promote consumer-driven behavior now using available tools and plan provisions...
  56. ncbi The drug budget silo mentality in Europe: an overview
    Lou Garrison
    Health Economics and Strategic Pricing, Roche Pharmaceuticals, Basel, Switzerland Office of Health Economics, London, UK
    Value Health 6:S1-9. 2003
  57. ncbi Pharmacy benefit management contracting: an assessment from a recent public sector procurement experience
    Jay P Bae
    Department of Economics, Andrew Young School of Policy Studies, Georgia State University, USA
    J Health Care Finance 29:49-56. 2002
    ..Those who are considering contracting with a PBM will find the assessment of the PBM industry timely and informative...
  58. ncbi The sad history of health care cost containment as told in one chart
    Drew E Altman
    Henry I Kaiser Family Foundation, Menlo Park, California, USA
    Health Aff (Millwood) . 2002
  59. ncbi The economics of prescription drug prices, government intervention, and the importation of drugs from Canada
    Matthew S Openshaw
    Public Policy and Political Economy, University of Texas at Dallas, Dallas, TX, USA
    Nurs Econ 23:307-11, 279. 2005
    ..What effects would this have on consumer prices, drug companies' incentives, and the development of new medications?..
  60. ncbi New York Medicaid: never can say goodbye
    Joseph Fastiggi
    Cornell J Law Public Policy 16:581-615. 2007
  61. ncbi Australian drugs scheme threatens free-trade talks
    David Fickling
    Lancet 363:299. 2004
  62. ncbi Reference pricing of pharmaceuticals for Medicare: evidence from Germany, The Netherlands, and New Zealand
    Patricia M Danzon
    University of Pennsylvania, USA
    Front Health Policy Res 7:1-54. 2004
    ..S. generic market, and on research and development (R&D) and the future supply of new drugs, because of the much larger U.S. share of global pharmaceutical sales...
  63. ncbi Managing healthcare costs within an integrated framework
    Rudy Fernandes
    Business Development and Market Access, Wyeth Ayerst Canada Inc
    Healthc Pap 3:70-6; discussion 87-94. 2002
    ..It is highly regarded for promoting effective treatment options, improving patient care and optimizing healthcare resource utilization--hence deserving serious consideration for reducing overall costs while achieving improved outcomes...
  64. ncbi Managing the cost of specialty pharmaceuticals
    Catherine A Kernich
    University Hospitals Health System, Cleveland, OH, USA
    Nurs Econ 22:245-50, 227. 2004
    ..This system includes working closely with providers and payers, underpinned with sound business planning techniques...
  65. ncbi How should we pay the piper when he's calling the tune? On the long-term affordability of cancer care in the United States
    Scott D Ramsey
    Fred Hutchinson Cancer Research Center, Seattle, WA, USA
    J Clin Oncol 25:175-9. 2007
  66. ncbi Medicaid: 10 fixes that work. Of all the reforms states have tried, these are the ones that hold the most promise
    Martha King
    State Legis 30:14-8. 2004
  67. ncbi A sustainable solution
    Mike Van Den Eynde
    Life Sciences and Health Care Practice, Deloitte Consulting LLP, USA
    AHIP Cover 47:36-8, 40-1. 2006
  68. ncbi Is a paradigm shift in US healthcare reimbursement inevitable?
    August M Watanabe
    Guidant Corporation, Indianapolis, Ind, USA
    Circulation 109:1456-9. 2004
  69. ncbi High prescription drug prices and the influence of the Food and Drug Administration
    Gary W Lawson
    Mayo Clin Proc 79:569; discussion 569-70. 2004
  70. ncbi Missouri Medicaid reform...what can physicians do?
    Larry W Halverson
    Cox Family Practice Residency, Springfield, USA
    Mo Med 103:102-5. 2006
  71. ncbi The humanizing of healthcare delivery. Tackling the high costs and closing the loopholes
    John Kerry
    Healthc Leadersh Rep 12:4-12. 2004
  72. ncbi ["Antibiotic stewardship": catchword or necessity?]
    S Bassetti
    Abteilung für Infektiologie, Bereich Innere Medizin, Kantonsspital Basel
    Praxis (Bern 1994) 93:623-5. 2004
  73. ncbi Controlling U.S. health spending: opportunities for academic health centers
    Gerard F Anderson
    Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA
    Acad Med 81:807-11. 2006
    ....
  74. ncbi Impact of formulary restrictions on the cost-effectiveness of antidepressant treatment
    David V Sheehan
    Department of Psychiatry and Behavioral Medicine, University of South Florida College of Medicine, Tampa, FL, USA
    Manag Care Q 10:21-31. 2002
    ..Assessment of overall cost-effectiveness should not be limited by acquisition costs but should take total healthcare costs into consideration...
  75. ncbi Creating the next generation of medical management
    Duncan Moore
    McKinsey and Company, Chicago, USA
    AHIP Cover 45:22-6, 28, 30. 2004
  76. doi Slowing the growth of health care costs--learning from international experience
    Karen Davis
    Commonwealth Fund, New York, USA
    N Engl J Med 359:1751-5. 2008
  77. ncbi Shifting the focus from cost to value: an employer perspective
    Pamela A Hymel
    Cisco Systems, 170 West Tasman Dr, Bldg 5 3, San Jose, CA 92886, USA
    J Manag Care Pharm 12:S6-10; quiz S24-6. 2006
    ..To review ways in which pharmacists can help health plans shift their focus from cost to value...
  78. ncbi Health care cost control. Getting on the right track
    Mick L Diede
    Manag Care 11:24-5, 29-33. 2002
  79. ncbi The changing face of managed care
    Debra A Draper
    Mathematica Policy Research, Washington, DC, USA
    Health Aff (Millwood) 21:11-23. 2002
    ..Consequently, purchasers and consumers face escalating health care costs under these changing conditions...
  80. ncbi The prescription-drug problem
    Robert Steinbrook
    N Engl J Med 346:790. 2002
  81. ncbi Control of prescription costs--is it possible?
    Patrick N Renaud
    Empl Benefits J 27:11-4. 2002
    ..The author considers two choices for controlling the cost of prescription drugs: Return the prescription drug program to the TPA, or implement plan design changes. Making changes to the buying habits of the public is key...
  82. ncbi Expenditures for prescription drugs: too much or not enough?
    Glen T Schumock
    College of Pharmacy, University of Illinois at Chicago, USA
    Healthc Financ Manage 57:34-8, 41. 2003
    ..Drug spending can be controlled by: Understanding the sources of drug cost Improving use of drug formularies Using clinical pharmacists to improve prescribing behavior...
  83. ncbi Save an arm and a leg
    David Stires
    Fortune 148:208, 210. 2003
  84. ncbi Living with GASB 45: how to manage liabilities associated with retiree medical benefits
    Frank Thoen
    Milliman, Inc, Seattle, USA
    Benefits Q 24:39-45. 2008
    ..Now is the time for employees and employers to work together and make difficult choices for keeping retiree medical costs and GASB 45 liabilities manageable...
  85. ncbi The impact of physician entrepreneurship on escalating health care costs
    Thomas Fletcher
    Austin Radiological Association, Austin, Texas 78746, USA
    J Am Coll Radiol 2:411-4. 2005
    ..This article explores the role of physician entrepreneurship in rising health care costs. Under the wrong circumstances, the invisible hand of the free market can become dysfunctional...
  86. ncbi Caveats of evaluating costs in critical care
    Albert E Holt
    Crit Care Med 32:299-300. 2004
  87. ncbi A critical review of cost reduction in neonatal intensive care. I. The structure of costs
    D K Richardson
    Department of Neonatology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
    J Perinatol 21:107-15. 2001
    ....
  88. ncbi In a bundling era, finding a fair price for ESRD services
    John D Sullivan
    Boston University, USA
    Nephrol News Issues 21:37, 39-40. 2007
  89. ncbi Managing prescription drug costs
    J M Sica
    Aon Consulting, Conshohocken, Pennsylvania, USA
    Empl Benefits J 26:35-40. 2001
    ..The author also discusses pharmacy benefit managers, as well as various utilization management strategies like benefit plan design and the use of formularies...
  90. ncbi Why do FEHBP and big unions excel at managing drug costs?
    Tony Berberabe
    Manag Care 12:36-9. 2003
  91. ncbi Reining in prescription drug costs
    Nancy Burns
    Remedi SeniorCare, USA
    Provider 34:33-5. 2008
  92. ncbi Workers' compensation reform
    Douglas C D'Andrea
    Division of Occupational and Environmental Medicine, Department of Medicine, University of Connecticut Health Center School of Medicine, 263 Farmington Avenue, Dowling North, Farmington, CT 06030 6210, USA
    Clin Occup Environ Med 4:vi, 259-71. 2004
    ..Future reform efforts will need to focus not only on the costs of the system but also its inclusiveness and support of the workers and their families it was intended to protect...
  93. pmc Attitudes toward the autopsy--an 8-state survey
    Peter N Nemetz
    Strategy and Business Economics Division, Sauder School of Business, University of British Columbia, Vancouver, British Columbia, Canada
    MedGenMed 8:80. 2006
    ..National autopsy rates have declined for several decades, and the reasons for such decline remain contentious...
  94. ncbi Pursuing cost containment in a pluralistic payer environment: from the aftermath of Clinton's failure at health care reform to the Balanced Budget Act of 1997
    Rick Mayes
    Department of Political Science, University of Richmond and Petris Centre on Health Care Markets and Consumer Welfare, University of California, Berkeley, CA, USA
    Health Econ Policy Law 1:237-61. 2006
    ..of President Clinton's attempt at comprehensive, public sector-led reform left managed care as the solution for cost control. And for a period it worked, largely because managed care organizations were able to both squeeze payments to ..
  95. ncbi [A 10-year-review (1998 - 2007) on 3449 cases of osteoporotic hip fractures: trend of hospitalization and inpatient costs]
    Zhi an Cheng
    Department of Orthopedics, The Second Affiliated Hospital of Guangzhou Traditional Chinese Medicine University, Guangzhou 510120, China
    Zhonghua Liu Xing Bing Xue Za Zhi 29:1128-31. 2008
    ....
  96. pmc Insights from a national survey into why substance abuse treatment units add prevention and outreach services
    Rebecca Wells
    Department of Health Policy and Administration, School of Public Health, University of North Carolina, Chapel Hill, North Carolina, USA
    Subst Abuse Treat Prev Policy 1:21. 2006
    ..Based on an ecological framework of organizational strategy, three categories of predictors were tested: (1) environmental, (2) unit-level, and (3) unit leadership...
  97. ncbi Modelling strategies for reducing pharmaceutical costs in hospital
    C R Macintyre
    Department of Public Health and Community Medicine, Westmead Hospital, New South Wales, Australia
    Int J Qual Health Care 13:63-9. 2001
    ..To describe drug utilization and cost in a large hospital and to compare the impact of different strategies on cost associated with drug prescribing...
  98. ncbi Using forecasting models to estimate the effects of changes in the composition of claims for selective serotonin reuptake inhibitors on expenditures
    C S Dewa
    Health Systems Research and Consulting Unit, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
    Clin Ther 23:292-306. 2001
    ..In addition, SSRIs were one of the major contributors to the growth in psychotropic medication expenditures during the past 5 years...
  99. ncbi Toward meeting the challenge of physician competence assessment: the University of California, San Diego Physician Assessment and Clinical Education (PACE) Program
    William A Norcross
    UCSD PACE Program, Department of Family and Preventive Medicine, University of California, San Diego, School of Medicine, La Jolla, California 92093 8204, USA
    Acad Med 84:1008-14. 2009
    ..for measuring competence and performance, including in-practice measures, (2) collaborative networking of assessment programs, (3) cost control, and (4) continued development of remedial measures that correspond to assessment findings.
  100. ncbi Massachusetts' approach to universal coverage: high hopes and faulty economic logic
    David U Himmelstein
    Department of Medicine, Cambridge Hospital Harvard Medical School, Cambridge, MA 02139, USA
    Int J Health Serv 37:251-7. 2007
    ..The legislation reflects a political calculus favoring private insurers, and ignores the imperative of cost control and the financial realities of cash-strapped families...
  101. ncbi [Ongoing health management control by cost monitoring through tracer indicators]
    H Villanueva
    Escuela de Salud Publica, Universidad Nacional de Cordoba, Hospital Estatal Domingo Funes, Cordoba, Argentina
    Rev Panam Salud Publica 10:405-12. 2001
    ....

Research Grants66

  1. Diversity-Oriented Synthesis of Novel Heterocyclic & Natural Product-Like Library
    MARVIN YU; Fiscal Year: 2009
    ..Other cost control techniques such as "two birds with one stone"-type fluorous tagging/ cleavage, sharing common building blocks, ..
  2. Swedish Neuroscience Institute / NEXT Consortium
    John W Henson; Fiscal Year: 2013
    ..Therefore, we will develop a set of performance metrics that will drive increases in data quality, efficiency, patient safety and cost control.
  3. MANAGED MENTAL HEALTH CARE & PATTERNS OF UTILIZATION
    Barbara Dickey; Fiscal Year: 1990
    ..These financial tools for cost control have received a great deal of research attention...
  4. ECONOMIC INFLUENCES (ESPECIALLY HMOS) ON CESAREANS
    A Tussing; Fiscal Year: 1990
    ..The research will add significantly to the literature on provider-induced demand for medical care; health maintenance organizations; and the determinants of cesareans. It has cost-control, medical, and ethical implications...
  5. QUALITY OF LIFE IN HIV+ AND PRIMARY CARE PATIENTS
    Joel Tsevat; Fiscal Year: 1991
    ..emphasize outcomes research, quality and effectiveness of care, technology assessment, practice guidelines, and cost control. Mortality data, while important, will not suffice: quality of life data will be pivotal...
  6. Oxygen Device For Persons With Respiratory Disability
    JOHN IZUCHUKWU; Fiscal Year: 2004
    ..Healthcare reform and continuing cost control measures have limited patient therapeutic choices to low-cost modalities regardless of effectiveness...
  7. VOLUME RESPONSE TO MEDICARE FEE CUTS WITH MULTI-PAYERS
    Ming Tai Seale; Fiscal Year: 1993
    Despite many cost control measures implemented in the 1980's, Medicare outlays to physicians continued to grow at double-digit rates...
  8. Optimal pricing of employer-based Health Plans
    Caroline Carlin; Fiscal Year: 2005
    ..Most employers are driven by cost control, and want to create an incentive for employees to enroll in efficient plans...
  9. PHYSICIAN-INDUCED DEMAND--PRIVATE AND PUBLIC SECTORS
    CHIMAN YIP; Fiscal Year: 1993
    ..If that is the case, then the intended goal of the MFS for cost control will be undermined...
  10. Ownership and Contracting for Quality Health Care
    Richard Zeckhauser; Fiscal Year: 2003
    ..The second component will develop a theoretical framework for analyzing how premium payment systems interact with provider payment to affect quality, cost and access. ..
  11. CONFERENCE: BEHAVIORAL HEALTH WORK FORCE EDUCATION
    Michael Hoge; Fiscal Year: 2002
    Over the past decade, a new paradigm in behavioral health care has emerged that emphasizes the following themes: cost control and cost effectiveness; evidence-based practice and the use of practice guidelines; patient safety; assessment ..
  12. PATIENT ADHERENCE AMONG CHRONIC DISEASE PATIENTS
    RONALD HAYS; Fiscal Year: 1990
    ..b>Cost control mechanisms are unlikely to succeed unless rates of noncompliance are substantially lowered...
  13. Bariatric Surgery Outcome/Cost in Medicare Beneficiaries
    David Flum; Fiscal Year: 2006
    ..at large, public reporting of postoperative deaths and complications at leading medical centers and because of cost control considerations...
  14. CORPORATIONS AND THE COST CONTAINMENT ISSUE
    HARVEY SAPOLSKY; Fiscal Year: 1980
    ..of corporate action are explored - involvement in local health care planning and sponsorship interest in health maintenance organizations as a cost control device. The study employs elite interview and organizational analysis methodology.
  15. A GOAL PROGRAMMING MODEL FOR NURSING SERVICE BUDGETING
    VANDANKUMAR TRIDEDI; Fiscal Year: 1980
    ..The model provides a vehicle for cost control by objective decision making in a harmonious fashion with collaboration between a hospital's financial ..
  16. COMPUTER ASSISTED SUPPORT FOR UNDER-SERVED SMOKERS
    FREDERICK BOCK; Fiscal Year: 2001
    ..An efficacy study will be used to examine the relative utility of this system compared to a low-cost control in an A-B-A design...
  17. The Spillover Effects of Health Insurance Coverage and Generosity
    Katherine Baicker; Fiscal Year: 2008
    ..unreadable] [unreadable] [unreadable]..
  18. NETWORK EFFECTS IN MENTAL HEALTH MANAGED CARE
    Thomas McGuire; Fiscal Year: 2002
    ..4) Test the behavior of the managed care plans against the predictions of the optimal network theory. ..
  19. Impact of Poor Health & AIDS on Small Businesses in SA
    Mark Pauly; Fiscal Year: 2003
    ..They will be useful for predicting the effect of changes in health on economic activity in this sector, and for allocating resources for disease prevention and treatment. ..
  20. Impact of the Medicare Part D Benzodiazepine Exclusion on Managed Care Patients
    Susan Ettner; Fiscal Year: 2008
    ..Our findings will inform the ongoing debate over amending Part D legislation to include BZD coverage by providing objective data to guide policymakers on the likely costs and benefits. [unreadable] [unreadable] [unreadable]..
  21. Treatment Patterns, Expenditures and Outcomes in MBHOs
    Susan Ettner; Fiscal Year: 2005
    ..e., how psychotherapy visits are associated with outcomes and expenditures. Selection models will be used to estimate this relationship for patients with and without drug use. ..
  22. Economics of Formulary Design and Mental Health Policy
    Haiden Huskamp; Fiscal Year: 2006
    ..Huskamp the training, mentoring, time and resources to develop the skills that will put her in a position to lead independent research on the economics of pharmaceutical treatment for mental illnesses. ..
  23. Nursing Home IT: Optimal Medication and Care Delivery
    Susan Horn; Fiscal Year: 2006
    ..Distill and summarize lessons learned about what is critical for successful implementation of HIT in nursing homes, including facilitators, barriers, and strategies to address them. ..
  24. Mental Health Spending and Quality of Care
    Thomas G McGuire; Fiscal Year: 2010
    ..Committee in June of 2007 suggested that the weak link between variation in spending and quality pointed toward cost control opportunities that will not affect outcomes...
  25. MH AND ADVERSE SELECTION IN MANAGED CARE
    Thomas McGuire; Fiscal Year: 2001
    ..Understanding how adverse selection works in managed care and what can be done about it should be a very high priority for research. ..
  26. Telemedicine-Based Collaborative Care to Reduce Rural Health Disparities
    John C Fortney; Fiscal Year: 2010
    ..This population is at high risk for experiencing health disparities and thus, interventions targeting this population have the potential to have a major impact. ..
  27. Economics of Racial & Ethnic Disparities in MH Services
    Thomas McGuire; Fiscal Year: 2005
    ..Test for evidence that patient reaction to provider discrimination leads to lower compliance rates and worse outcomes for these minorities. ..
  28. Costs of Preventing Alcohol Problems in Older Adults
    Susan Ettner; Fiscal Year: 2007
    ..abstract_text> ..
  29. Effects of Mental Parity on High-Cost and Severely-Ill Individuals
    Haiden A Huskamp; Fiscal Year: 2011
    ..We will estimate a combination of two-part random-effects models for longitudinal data, latent class random-effects models, logistic regression models, Poisson regression models, and hazard models to address these aims. ..
  30. Comparative Effectiveness of Comprehensive Care for Adults with SMI
    TODD PATRICK GILMER; Fiscal Year: 2010
    ....
  31. Regionalizing Cancer Surgery
    Vivian Ho; Fiscal Year: 2007
    ..The analyses will also serve as case studies to determine the value and feasibility of analyzing a wider range of surgeries using these methods. [unreadable] [unreadable] [unreadable]..
  32. Telephone Counseling: Men w/Prostate CA & Partners
    Terry Badger; Fiscal Year: 2007
    ..Data will be analyzed through descriptive statistics, a series of two-way mixed design ANOVAs and individual regression analyses. [unreadable] [unreadable] [unreadable]..
  33. Flow Instrument for Two-color Assay on Microtransponders
    Wlodek Mandecki; Fiscal Year: 2007
    ..The flow reader can be used for diagnostics in vitro and drug discovery projects. [unreadable] [unreadable] [unreadable]..
  34. How child welfare inter-agency cooperation may reduce youth HIV risk behaviors
    Rebecca Wells; Fiscal Year: 2007
    ..These findings will inform managers of related health and social services.yield actionable guidance to child welfare agency managers and policy makers in allocating scarce resources. [unreadable] [unreadable] [unreadable]..
  35. Mechanisms and Moderators of Behavior Change in Alcoholics Anonymous
    John Kelly; Fiscal Year: 2008
    ..unreadable] [unreadable] [unreadable]..
  36. Fractures, Heart Disease, and Stroke on Aromatase Inhibitors
    Nancy L Keating; Fiscal Year: 2010
    ....
  37. Informatics based nurse triage in lung transplant care
    Stanley Finkelstein; Fiscal Year: 2008
    ..unreadable] [unreadable]..
  38. Roots of Health Disparities: The Quality of Primary Care
    Peter Bach; Fiscal Year: 2008
    ..The significance of these findings would be that a singular approach to improving the quality of care provided by physicians should enhance care quality overall and reduce healthcare disparities. ..
  39. Adoption of Buprenorphine in an HMO Setting
    Dennis McCarty; Fiscal Year: 2009
    ..Aim 3: Identify factors that facilitate and inhibit the adoption and use of buprenorphine through interviews with 530 patients and 96 practitioners and administrators. ..
  40. Improving Quality and Reducing Disparities: Complementary or Competing Goals
    David Blumenthal; Fiscal Year: 2007
    ..The Harvard interfaculty Program for Health Systems Improvement will be responsible for the planning and execution of the meeting. [unreadable] [unreadable] [unreadable]..
  41. Impact of Prior Approval for Antidepressants in Medicaid
    Stephen Soumerai; Fiscal Year: 2007
    ..All analyses will be stratified by type of disability (mental, physical, developmental). ..
  42. DEVELOPMENT OF A VACCINE FOR HUMAN PERIODONTITIS
    ROY PAGE; Fiscal Year: 2001
    ..These observations will contribute in a major way to closing the gaps in our knowledge of the role of the host immune response in the pathogenesis of periodontitis. ..
  43. IMPROVING HEALTH BEHAVIOR AND OUTCOMES AFTER ANGIOPLASTY
    Mary Charlson; Fiscal Year: 2002
    ..abstract_text> ..
  44. CONSTRUCTING NEUROTROPHIN FIELDS IN THE BRAIN
    W Saltzman; Fiscal Year: 2002
    ..abstract_text> ..
  45. Exacerbation of Alzheimer's Disease by Nitrous Oxide
    W Kofke; Fiscal Year: 2003
    ..Moreover, observation of a protective effect may result in discovery of an easily implemented preventative drug therapy for AD. ..
  46. ESCAPE Mechanistic Substudies
    Robert Califf; Fiscal Year: 2003
    ..Catecholamines are also being collected at baseline and 3 months. In addition, the ESCAPE investigators are all ready capturing detailed demographic, clinical, and physiological information as part of the protocol for the primary study. ..
  47. Mental Health and Labor Market Outcomes
    Roland Sturm; Fiscal Year: 2004
    ....
  48. Reducing benzodiazepines and hip fracture in the elderly
    Stephen Soumerai; Fiscal Year: 2004
    ..Phase II analyses will also contribute a novel method for evaluating health outcomes of changes in medication use in large populations. ..
  49. Cell-based Assay on Microtransponders
    Wlodek Mandecki; Fiscal Year: 2004
    ..The benefits of the program involve the advancement of cell-based assay technology, acceleration of drug discovery programs in research laboratories and pharmaceutical industry, and cost savings. ..
  50. Cost-Related Underuse of Medications in the Elderly
    Stephen Soumerai; Fiscal Year: 2006
    ..unreadable] [unreadable]..
  51. Impact/HIV Intervention/Adolescent Males Leaving Jail
    Nicholas Freudenberg; Fiscal Year: 2005
    ..This sub-study will also be used to tailor the intervention tested in this proposal for adolescent females. ..
  52. Adoption of Buphenorphine in Office Practice
    STANLEY WALLACK; Fiscal Year: 2006
    ..abstract_text> ..
  53. Specialty Mental Health Care--Expanding Access in an HMO
    Dominic Hodgkin; Fiscal Year: 2003
    ..The results will inform health plan decision-makers and others as they make utilization management choices that may have a major impact on patients and enrollee populations overall. ..
  54. LINKING OCCUPATIONAL INJURY AND ILLNESS DATA BASES
    Kenneth Rosenman; Fiscal Year: 2002
    ..We have assembled an interdisciplinary team consisting of an occupational health physician, epidemiologists, a biostatistician and a computer programmer. We have arranged access to all nine data systems. ..
  55. COST-EFFECTIVENESS ANALYSIS OF SURGERY IN EPILEPSY-CEASE
    John Langfitt; Fiscal Year: 2001
    ..Identifying the most valid utilization and preference assessment methods will help future investigators make informed, data-based choices of measures for outcomes studies in patients with epilepsy and other chronic, neurologic diseases. ..
  56. A Randomized Trial of Home Self-Efficacy Enhancement
    Anthony Jerant; Fiscal Year: 2007
    ..The findings will help policymakers, payers, and providers identify which interventions to implement. ..
  57. Analyzing Vaccine Programs/Policies in Western Europe
    Gary Freed; Fiscal Year: 2004
    ..abstract_text> ..
  58. Modeling CJ Involvemment Among PMI
    William Fisher; Fiscal Year: 2005
    ....
  59. Selection and the Quality Impact of Nursing Home Ownership
    David C Grabowski; Fiscal Year: 2010
    ..By examining this relationship using a novel empirical strategy, this study provides an opportunity to improve the quality of care for the millions of Americans receiving care in the nursing home setting. ..
  60. Leveraging Medicare Payment & Reporting Policies to Improve Nursing Home Quality
    David C Grabowski; Fiscal Year: 2010
    ..Thus, the information derived from this study has the potential to make important research and policy-relevant contributions aimed at improving the quality of care for all nursing home residents. ..